A trial pitting weight loss jab Mounjaro against competitor Wegovy ended with one clear winner, and Mounjaro is getting ...

Popular weight loss drugs such as Wegovy and Zepbound have shown incredible success in clinical trials. But in the real world ...

Real-world cost barriers and insurance denials contribute to early discontinuation of injectable glucagon-like peptide-1 (GLP ...

The stylist behind Jenna Bush Hager’s bob haircut shares his secrets, are GLP-1 drugs or bariatric surgery better for weight ...

In March, the Food and Drug Administration approved Vykat XR, an extended-release version of the existing drug diazoxide choline, which eases the relentless hunger and may offer insights into the ...

Glucagon-Like-Peptide-1 Agonists, like Ozempic, have become extremely popular for weight loss. Here are some of the side ...

When researchers analyzed weight loss results from patients who took GLP-1 drugs and those who'd undergone bariatric surgery, one method led to much more weight loss.

GLP-1 drugs show promise in diabetes management, offering heart and kidney benefits, but also highlight the need for ...

Many focus on what weight-loss drugs take away: pounds. But they also offer patients something new: a sense of agency.

Given the increasing use of GLP-1s, IFF recently released a report highlighting how the rapidly growing GLP-1 consumer market ...

As more CFOs step into the public spotlight by participating in events and conferences, the cost of misspeaking and the importance of leadership alignment on policy are increasing.